THE INVESTIGATIONAL PRODUCT: HCQ
malaria, rheumatic diseases
MALARIA, RHEUMATIC DISEASES
Hydroxychloroquine is an inexpensive and globally accessible drug indicated for the treatment of rheumatic diseases and as both a treatment and a prophylaxis for malaria.Despite the attention and hope generated by HCQ in other parts of the country and the subregion, at the study site, information became widely available that HCQ was not a viable option for treatment. Notably, the U.S. Food and Drug Administration’s withdrawal of the EUA was widely shared by the media and on social media locally.